• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆致动脉粥样硬化指数作为2型糖尿病慢性肾脏病和肝损伤的早期标志物

Atherogenic Index of Plasma as an Early Marker of Chronic Kidney Disease and Liver Injury in Type 2 Diabetes.

作者信息

Li Huifang, Miao Xia, Zhong Jiaoying, Zhu Zhaoming

机构信息

Department of Nephrology, Hebei Yiling Hospital, Shijiazhuang, Hebei, China.

出版信息

Clin Med Insights Endocrinol Diabetes. 2024 Jun 9;17:11795514241259741. doi: 10.1177/11795514241259741. eCollection 2024.

DOI:10.1177/11795514241259741
PMID:38859965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11163926/
Abstract

BACKGROUND

Diabetic kidney disease (DKD) is the main cause of end-stage renal disease and has a high mortality rate. Currently, no effective treatments are available to reduce the progression of kidney damage associated with diabetes.

OBJECTIVES

To explore the influence and predictive value of the atherogenic index of plasma (AIP) on early chronic kidney disease and liver injury in patients with type 2 diabetes mellitus (T2DM).

METHODS

Medical records of 1057 hospitalized adult patients with T2DM between January 2021 and December 2022 were collected. The predictive value of AIP, renal function, and liver injury in patients with T2DM were analyzed using Pearson's correlation, multiple logistic regression, and receiver operating characteristic (ROC) curve analyses.

RESULTS

AIP was a sensitive indicator of early liver and kidney injury in patients with T2DM. Patients in the DKD group showed increased AIP that positively correlated with serum creatinine, uric acid, and β2-microglobulin levels. Increased AIP negatively correlated with estimated glomerular filtration rate (eGFR). AIP significantly correlated with alanine aminotransferase and aspartate aminotransferase levels and glutamyl transpeptidase-to-platelet ratio (GPR). An eGFR of 60-100 mL/min/1.73 m significantly increased the risk of DKD as the AIP increased. At lower GPR levels, the risk of DKD significantly increased with increasing AIP. However, no significant difference was found between the 2 groups when the GPR was >0.1407. The ROC curve analysis showed that AIP could predict early liver injury.

CONCLUSIONS

AIP is directly involved in early liver and kidney injury in T2DM and may be a sensitive indicator for early detection.

摘要

背景

糖尿病肾病(DKD)是终末期肾病的主要病因,死亡率很高。目前,尚无有效的治疗方法可减少与糖尿病相关的肾脏损害进展。

目的

探讨血浆致动脉粥样硬化指数(AIP)对2型糖尿病(T2DM)患者早期慢性肾脏疾病和肝损伤的影响及预测价值。

方法

收集2021年1月至2022年12月期间1057例住院成年T2DM患者的病历。采用Pearson相关性分析、多元逻辑回归分析和受试者工作特征(ROC)曲线分析,分析AIP、肾功能和肝损伤在T2DM患者中的预测价值。

结果

AIP是T2DM患者早期肝、肾损伤的敏感指标。DKD组患者的AIP升高,与血清肌酐、尿酸和β2-微球蛋白水平呈正相关。AIP升高与估算肾小球滤过率(eGFR)呈负相关。AIP与丙氨酸氨基转移酶、天冬氨酸氨基转移酶水平及谷氨酰转肽酶与血小板比值(GPR)显著相关。当eGFR为60-100 mL/min/1.73 m²时,随着AIP升高,DKD风险显著增加。在较低的GPR水平下,随着AIP升高,DKD风险显著增加。然而,当GPR>0.1407时,两组之间未发现显著差异。ROC曲线分析表明,AIP可预测早期肝损伤。

结论

AIP直接参与T2DM患者的早期肝、肾损伤,可能是早期检测的敏感指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f999/11163926/bb5e12f60fcb/10.1177_11795514241259741-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f999/11163926/d5f9fbac38c4/10.1177_11795514241259741-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f999/11163926/01590d9a1b28/10.1177_11795514241259741-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f999/11163926/bb5e12f60fcb/10.1177_11795514241259741-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f999/11163926/d5f9fbac38c4/10.1177_11795514241259741-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f999/11163926/01590d9a1b28/10.1177_11795514241259741-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f999/11163926/bb5e12f60fcb/10.1177_11795514241259741-fig3.jpg

相似文献

1
Atherogenic Index of Plasma as an Early Marker of Chronic Kidney Disease and Liver Injury in Type 2 Diabetes.血浆致动脉粥样硬化指数作为2型糖尿病慢性肾脏病和肝损伤的早期标志物
Clin Med Insights Endocrinol Diabetes. 2024 Jun 9;17:11795514241259741. doi: 10.1177/11795514241259741. eCollection 2024.
2
Diagnostic value of α1-MG and URBP in early diabetic renal impairment.α1-微球蛋白和尿视黄醇结合蛋白在早期糖尿病肾损伤中的诊断价值
Front Physiol. 2023 Oct 19;14:1173982. doi: 10.3389/fphys.2023.1173982. eCollection 2023.
3
Serum Uric Acid is a Better Indicator of Kidney Impairment Than Serum Uric Acid-to-Creatinine Ratio and Serum Uric Acid-to-High-Density Lipoprotein Ratio: A Cross-Sectional Study of Type 2 Diabetes Mellitus Patients.血清尿酸比血清尿酸与肌酐比值及血清尿酸与高密度脂蛋白比值更能反映肾脏损伤:一项2型糖尿病患者的横断面研究
Diabetes Metab Syndr Obes. 2023 Sep 5;16:2695-2703. doi: 10.2147/DMSO.S425511. eCollection 2023.
4
Impact of baseline and trajectory of the atherogenic index of plasma on incident diabetic kidney disease and retinopathy in participants with type 2 diabetes: a longitudinal cohort study.载脂蛋白相关指数基线水平和变化轨迹对 2 型糖尿病患者糖尿病肾病和视网膜病变发病的影响:一项纵向队列研究。
Lipids Health Dis. 2024 Jan 11;23(1):11. doi: 10.1186/s12944-024-02003-5.
5
Correlations of Serum Retinol-Binding Protein and Stromal Cell-Derived Factor-1 with Renal Function in Patients with Diabetic Kidney Disease.血清视黄醇结合蛋白和基质细胞衍生因子-1 与糖尿病肾病患者肾功能的相关性。
Clin Lab. 2024 Jan 1;70(1). doi: 10.7754/Clin.Lab.2023.211254.
6
Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.血清组织蛋白酶 S 在 2 型糖尿病肾病中的诊断价值。
Front Endocrinol (Lausanne). 2023 May 25;14:1180338. doi: 10.3389/fendo.2023.1180338. eCollection 2023.
7
Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes.心血管代谢指数与 2 型糖尿病患者糖尿病肾病风险的相关性。
Cardiovasc Diabetol. 2024 Apr 25;23(1):142. doi: 10.1186/s12933-024-02228-9.
8
The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines.糖尿病视网膜和肾脏微血管病变之间的联系与血脂异常和循环中细胞因子水平上调有关。
Front Public Health. 2023 Jan 17;10:1040319. doi: 10.3389/fpubh.2022.1040319. eCollection 2022.
9
Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.机器学习算法在 2 型糖尿病合并糖尿病肾病患者终末期肾病风险预测模型中的开发与内部验证。
Ren Fail. 2022 Dec;44(1):562-570. doi: 10.1080/0886022X.2022.2056053.
10
The Serum Uric Acid to Serum Creatinine Ratio is an Independent Risk Factor for Diabetic Kidney Disease.血清尿酸与血清肌酐比值是糖尿病肾病的独立危险因素。
Diabetes Metab Syndr Obes. 2022 Nov 28;15:3693-3703. doi: 10.2147/DMSO.S387426. eCollection 2022.

引用本文的文献

1
Novel Lipid Biomarkers and Microvascular Complications in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis.糖尿病患者的新型脂质生物标志物与微血管并发症:一项系统评价和荟萃分析
Clin Med Insights Endocrinol Diabetes. 2025 Aug 16;18:11795514251365301. doi: 10.1177/11795514251365301. eCollection 2025.
2
Association between the atherogenic index of plasma and mortality in the chronic kidney disease population: evidence from NHANES.慢性肾脏病患者血浆致动脉粥样硬化指数与死亡率之间的关联:来自美国国家健康与营养检查调查(NHANES)的证据
Front Med (Lausanne). 2025 May 30;12:1575657. doi: 10.3389/fmed.2025.1575657. eCollection 2025.
3

本文引用的文献

1
Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross-sectional survey of a regional cohort.2 型糖尿病患者血脂异常不同水平和模式与肾小球滤过率的相关性:一项区域性队列的横断面研究。
J Clin Lab Anal. 2023 Jul;37(13-14):e24954. doi: 10.1002/jcla.24954. Epub 2023 Aug 3.
2
Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease.糖尿病肾病生物标志物在预测代谢相关脂肪性肝病中的意义
Biomedicines. 2023 Jul 7;11(7):1928. doi: 10.3390/biomedicines11071928.
3
Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney disease.
Association of atherogenic index of plasma with kidney dysfunction in diabetic individuals: findings from two national population-based studies.
糖尿病患者血浆致动脉粥样硬化指数与肾功能不全的关联:两项基于全国人群研究的结果
BMC Endocr Disord. 2025 Apr 18;25(1):105. doi: 10.1186/s12902-025-01925-0.
4
The Interplay Between Carotid Intima-Media Thickness and Selected Serum Biomarkers in Various Stages of Chronic Kidney Disease.慢性肾脏病各阶段颈动脉内膜中层厚度与选定血清生物标志物之间的相互作用
Biomedicines. 2025 Feb 1;13(2):335. doi: 10.3390/biomedicines13020335.
5
Association between atherogenic index of plasma and type 2 diabetic complications: a cross-sectional study.血浆致动脉粥样硬化指数与2型糖尿病并发症之间的关联:一项横断面研究。
Front Endocrinol (Lausanne). 2025 Feb 4;16:1537303. doi: 10.3389/fendo.2025.1537303. eCollection 2025.
6
Nonlinear association between atherogenic index of plasma and chronic kidney disease: a nationwide cross-sectional study.血浆致动脉粥样硬化指数与慢性肾脏病的非线性关联:一项全国性横断面研究。
Lipids Health Dis. 2024 Sep 27;23(1):312. doi: 10.1186/s12944-024-02288-6.
鉴定和验证与糖尿病肾病相关的免疫生物标志物、潜在调节因子和治疗靶点。
BMC Med Genomics. 2023 May 1;16(1):90. doi: 10.1186/s12920-023-01519-6.
4
Association of triglycerides to high-density lipoprotein cholesterol ratio with incident cardiovascular disease but not end-stage kidney disease among patients with biopsy-proven diabetic nephropathy.在经活检证实的糖尿病肾病患者中,三酰甘油与高密度脂蛋白胆固醇比值与心血管疾病事件的发生相关,但与终末期肾病无关。
Hypertens Res. 2023 Jun;46(6):1423-1432. doi: 10.1038/s41440-023-01197-y. Epub 2023 Feb 7.
5
Sex-specific differences in the effect of the atherogenic index of plasma on prediabetes and diabetes in the NHANES 2011-2018 population.人群中载脂蛋白指数对 2011-2018 年 NHANES 前期糖尿病和糖尿病的影响存在性别差异。
Cardiovasc Diabetol. 2023 Jan 30;22(1):19. doi: 10.1186/s12933-023-01740-8.
6
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases.早期干预和强化管理糖尿病、心肾和代谢疾病患者。
J Diabetes Complications. 2023 Feb;37(2):108389. doi: 10.1016/j.jdiacomp.2022.108389. Epub 2023 Jan 3.
7
Evaluating the use of novel atherogenicity indices and insulin resistance surrogate markers in predicting the risk of coronary artery disease: a case‒control investigation with comparison to traditional biomarkers.评估新型动脉粥样硬化指数和胰岛素抵抗替代标志物在预测冠心病风险中的应用:与传统生物标志物比较的病例对照研究。
Lipids Health Dis. 2022 Nov 26;21(1):126. doi: 10.1186/s12944-022-01732-9.
8
Cellular Senescence in Metabolic-Associated Kidney Disease: An Update.代谢相关性肾脏疾病中的细胞衰老:最新研究进展。
Cells. 2022 Oct 31;11(21):3443. doi: 10.3390/cells11213443.
9
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.代谢相关性脂肪性肝病(MAFLD)的分子机制:脂质代谢途径的功能分析。
Clin Sci (Lond). 2022 Sep 30;136(18):1347-1366. doi: 10.1042/CS20220572.
10
Correction: Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom.更正:甘油三酯升高和高密度脂蛋白胆固醇降低与晚期慢性肾脏病的发病独立相关:一项对来自英国的911,360人的队列研究。
BMC Nephrol. 2022 Sep 21;23(1):318. doi: 10.1186/s12882-022-02948-8.